Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-23

Clinical Trial Update: Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and an IV (Bolus) Infusion of Eribulin in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and tolerability of co-administering oral ketoconazole with an IV bolus of eribulin in patients with advanced solid tum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eribulin (eribulin mesilate)
  • Ketoconazole (Ketoconazole)

Snippet

Sponsor: Eisai Limited | Conditions: Cancer | Phase 1 | Status: COMPLETED | Results posted: 2013-09-23